Abstract:Human calcitonin (hCT) is a polypeptide hormone that participates in calcium-phosphorus metabolism. Irreversible aggregation of 32-amino acid hCT into β-sheet-rich amyloid fibrils impairs physiological activity and increases the risk of medullary carcinoma of the thyroid. Amyloid-resistant hCT derivatives substituting critical amyloidogenic residues are of particular interest for clinical applications as therapeutic drugs against bone-related diseases. Uncovering the aggregation mechanism of hCT at the molecular level, therefore, is important for the design of amyloid-resistant hCT analogues. Here, we investigated the aggregation dynamics of hCT, non-amyloidogenic salmon calcitonin (sCT), and two hCT analogues with reduced aggregation tendency─TL-hCT and phCT─using long timescale discrete molecular dynamics simulations. Our results showed that hCT monomers mainly adopted unstructured conformations with dynamically formed helices around the central region. hCT self-assembled into helix-rich oligomers first, followed by a conformational conversion into β-sheet-rich oligomers with β-sheets formed by residues 10-30 and stabilized by aromatic and hydrophobic interactions. Our simulations confirmed that TL-hCT and phCT oligomers featured more helices and fewer β-sheets than hCT. Substitution of central aromatic residues with leucine in TL-hCT and replacing C-terminal hydrophobic residue with hydrophilic amino acid in phCT only locally suppressed β-sheet propensities in the central region and C-terminus, respectively. Having mutations in both central and C-terminal regions, sCT monomers and dynamically formed oligomers predominantly adopted helices, confirming that both central aromatic and C-terminal hydrophobic residues played important roles in the fibrillization of hCT. We also observed the formation of β-barrel intermediates, postulated as the toxic oligomers in amyloidosis, for hCT but not for sCT. Our computational study depicts a complete picture of the aggregation dynamics of hCT and the effects of mutations. The design of next-generation amyloid-resistant hCT analogues should consider the impact on both amyloidogenic regions and also take into account the amplification of transient β-sheet population in monomers upon aggregation.

Inhibition of the Fibrillation of Highly Amyloidogenic Human Calcitonin by Cucurbit[7]uril with Improved Bioactivity

Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations

Cucurbit[7]-assisted Sustained Release of Human Calcitonin from Thermosensitive Block Copolymer Hydrogel.

Dopamine-Conjugated Carbon Dots Inhibit Human Calcitonin Fibrillation

Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants

Cell Active and Functionally-Relevant Small-Molecule Agonists of Calcitonin Receptor.

Modulation of the Fibrillation Kinetics and Morphology of a Therapeutic Peptide by Cucurbit[7]uril

Growth-incompetent Monomers of Human Calcitonin Lead to a Noncanonical Direct Relationship Between Peptide Concentration and Aggregation Lag Time

Curcumin Inhibits Transforming Growth Factor-Beta Activity Via Inhibition of Smad Signaling in HK-2 Cells.

Deciphering the Influence of Y12L and N17H Substitutions on the Conformation and Oligomerization of Human Calcitonin

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Supramolecular nanoassemblies of salmon calcitonin and aspartame for fibrillation inhibition and osteogenesis improvement

Synthesis of Fe 3 O 4 -Chlorophyllin Nanoparticles for Preventing Amyloid Formation by Human Calcitonin

Peptide Engineering Approach to Introduce an Improved Calcitonin Mutant

Differential Modulation of the Aggregation of N-terminal truncated Aβ via Cucurbiturils.

Unveiling the Inhibitory Effect of Magnolol in the Aggregation of Human Calcitonin (hCT): A Comprehensive In-Silico Study

Peroxynitrite scavenger FeTPPS bind with hCT to effectively inhibit its amyloid aggregation

Sulfated alginate based complex for sustained calcitonin delivery and enhanced osteogenesis

Inhibition of amyloidal aggregation of insulin by amino acid conjugated bile acids: An insight into the possible role of biosurfactants in modulating the fibrillation kinetics and cytotoxicity

Enhancement of Oral Bioavailability of Salmon Calcitonin Through Chitosan-Modified, Dual Drug-Loaded Nanoparticles.

Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors